Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial2026.09.23
Novo Nordisk confirms stable Ozempic® supply across Canada                                                                2026.09.18
Ozempic® Savings Card Program Expanded for Patients with Private Coverage                                                                2026.07.06
Novo Nordisk introduces updated Rybelsus® tablet formulation in Canada for adults living with type 2 diabetes                                                                2026.06.09
Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®                                                                2026.05.26
Novo Nordisk Canada and Rexall Pharmacy partner to offer convenience, support, and home delivery for Canadians taking Ozempic® and Wegovy®2026.05.13
Ten Mississauga Schools Join City-Wide Initiative to Enhance Student Health and Well-Being                                                                2026.04.13
Health Canada approves Ozempic® (semaglutide injection) to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes2026.03.02
Health Canada approves RYBELSUS® (semaglutide tablets) to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes2026.01.12
Wegovy® (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH, a Serious Liver Disease2025.12.15
Sogroya® (somapacitan injection) now available in Canada as the first and only once-weekly treatment for both children and adults living with growth hormone deficiency2025.10.15
Novo Nordisk Canada and Pocketpills Announce Collaboration to Provide Enhanced Online Pharmacy and Prescription Services and Support for Ozempic® and Wegovy®2025.09.18
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease2025.08.19
Growing Healthy Places: Mississauga to support children’s health and well-being across the city2025.03.20
Léger survey shows four out of five Quebecers call for greater support for obesity from the government and public health system2024.10.21
Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases2023.08.10
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity2023.04.12
Creation of a National Training Program for Healthcare Professionals Involved in Obesity Prevention and Care2022.04.05
Continued Support for Banting and Best’s Insulin Discovery and Research at the University of Toronto
2021.04.12
Novo Nordisk and the University of Toronto announce joint 200 DKK million investment to address diabetes and chronic disease prevention 2021.02.24

Camp Huronda receives $1.5M donation to rebuild on-site medical centre

 2021.01.14
Camp Huronda infographic                                                                                                                                                    2021.01.14